Company / Inventory
TherapeuticsMD, Inc. Inventory History
FY2015-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$7.6M
FY2021
5-year range
$7.6M / $8.0M
FY2017-FY2021
Trend
-4.6%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $12M to $8M over the past 2 years.
Based on SEC 10-K filings.
$8M in FY2021 with a 5-year CAGR of +47.9%.
Declined from $12M to $8M over the past 2 years.
Inventory over time
Growth rates
- 3-Year CAGR
- +32.6%
- 5-Year CAGR
- +47.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +47.9%, indicating consistent growth.
- In FY2021, inventory decreased 4.6% year-over-year.
- Peak inventory was recorded in FY2019.
- Lowest inventory in the period was in FY2015.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.77 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | $7.6M | -4.6% |
| FY2020 | $8.0M | -32.6% |
| FY2019 | $11.9M | +263.0% |
| FY2018 | $3.3M | +120.0% |
| FY2017 | $1.5M | +38.0% |
| FY2016 | $1.1M | +56.0% |
| FY2015 | $690.2K | -41.6% |
As of FY2021 · SEC 10-K · Updated Jun 28, 2026